Tiezheng (Kevin) Li is a Senior Scientist at Arcellx, with previous experience at Jecho Laboratories, Inc. working in Analytical Development. Prior to that, Tiezheng (Kevin) Li was a Postdoctoral Research Fellow at the University of Maryland College Park, specializing in therapeutic IgG antibody glycoengineering. Tiezheng (Kevin) Li earned a Ph.D. in Biochemistry and Molecular Biology from Marquette University, conducting research in bacterial lipopolysaccharide O-antigen biosynthesis.
November, 2022 - present
July, 2021